Jason A. Rosenzweig to Disease Models, Animal
This is a "connection" page, showing publications Jason A. Rosenzweig has written about Disease Models, Animal.
Connection Strength
0.174
-
Rosenzweig JA, Ahmed S, Eunson J, Chopra AK. Low-shear force associated with modeled microgravity and spaceflight does not similarly impact the virulence of notable bacterial pathogens. Appl Microbiol Biotechnol. 2014 Nov; 98(21):8797-807.
Score: 0.088
-
Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.
Score: 0.025
-
Sha J, Rosenzweig JA, Kozlova EV, Wang S, Erova TE, Kirtley ML, van Lier CJ, Chopra AK. Evaluation of the roles played by Hcp and VgrG type 6 secretion system effectors in Aeromonas hydrophila SSU pathogenesis. Microbiology (Reading). 2013 Jun; 159(Pt 6):1120-1135.
Score: 0.020
-
Sha J, Rosenzweig JA, Kirtley ML, van Lier CJ, Fitts EC, Kozlova EV, Erova TE, Tiner BL, Chopra AK. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague. Microb Pathog. 2013 Feb; 55:39-50.
Score: 0.019
-
Wiley DJ, Nordfeldth R, Rosenzweig J, DaFonseca CJ, Gustin R, Wolf-Watz H, Schesser K. The Ser/Thr kinase activity of the Yersinia protein kinase A (YpkA) is necessary for full virulence in the mouse, mollifying phagocytes, and disrupting the eukaryotic cytoskeleton. Microb Pathog. 2006 May; 40(5):234-43.
Score: 0.012
-
Edgeworth RL, San JH, Rosenzweig JA, Nguyen NL, Boyer JD, Ugen KE. Vaccine development against HIV-1: current perspectives and future directions. Immunol Res. 2002; 25(1):53-74.
Score: 0.009